Features Partner Sites Information LinkXpress
Sign In
Demo Company

Mushrooms Help Raise Vitamin D Levels

By BiotechDaily International staff writers
Posted on 07 May 2013
Print article
Eating mushrooms may be as effective at raising serum vitamin D levels as taking vitamin D2 or D3 supplements, according to a new study.

Researchers at Boston University (MA, USA) conducted a study that randomized 30 adults (mean age 35.2), to one of three interventions taken once a day for 12 weeks during the winter. The first involved capsules containing 2,000 IU of vitamin D3; the second involved capsules containing 2,000 IU of vitamin D2; while the third involved extract of dried white button mushrooms (Agaricus bisporus) containing 2,000 IU of vitamin D2. All patients had similar baseline levels of serum vitamin 25(OH)D. In all, 25 patients completed all 12 weeks of the study.

The results showed that serum vitamin D levels gradually increased until they reached a plateau at about 7 weeks for all three groups, and were maintained for the next 5 weeks. According to the researchers, the results confirm other studies that have shown eating vitamin D2—as fortified orange juice, a supplement, or a pharmaceutical formulation--can increase total circulating serum D levels for at least 3 months, and up to 6 years. The study was presented at the joint American Society for Biochemistry and Molecular Biology and the Experimental Biology meeting, held during April 2013 in Boston (MA, USA).

“These results provide evidence that ingesting mushrooms […] can improve the vitamin D status of healthy adults,” said lead author and study presenter Michael Holick, MD, PhD. “Exposing mushrooms to ultraviolet light can produce vitamins D3 and D4 as well, giving patients additional vitamin D.”

Mushrooms produce vitamin D2 (ergocalciferol) when exposed to sunlight or ultraviolet radiation, in a similar process by which humans produce vitamin D3 (cholecalciferol). Not all plants possess this property, but fungi, seaweed, and yeast do. Clinicians recommend vitamin D3 supplements, particularly for those who are vitamin D deficient or insufficient, but studies have shown vitamin D2 to be effective at increasing serum levels of the vitamin as well.

Related Links:

Boston University

Print article



view channel
Image: Glioblastoma multiforme (GBM) (Photo courtesy of the University of California, San Diego School of Medicine).

How Blocking TROY Signaling Slows Brain Cancer Growth

Cancer researchers have found how the low molecular weight drug propentofylline (PPF) slows the growth of the aggressive brain tumor glioblastoma multiforme (GBM). This form of brain cancer is the most... Read more


view channel
Image: A partially completed three-dimensional printed airway from nostril to trachea with fine structure of the nasal cavity showing (Photo courtesy of Dr. Rui Ni, Pennsylvania State University).

The Structure of the Nasal Cavity Channels Food Smells into the Nose and Avoids the Lungs

Three-dimensional printing technology was used to create a model of the nasal cavity that enabled researchers to demonstrate why the smell of food goes into the nose rather than down into the lungs.... Read more


view channel

Molecular Light Shed on “Dark” Cellular Receptors

Scientists have created a new research tool to help find homes for orphan cell-surface receptors, toward better understanding of cell signaling, developing new therapeutics, and determining causes of drug side-effects. The approach may be broadly useful for discovering interactions of orphan receptors with endogenous, naturally... Read more

Lab Technologies

view channel
Image:  The BioSpa 8 Automated Incubator (Photo courtesy of BioTek Instruments).

Smart Incubator System Automates Live Cell Assay Operations

A new instrument that automates laboratory workflow by linking microplate washers and dispensers with readers and imaging systems is now available for biotech and other life sciences researchers.... Read more


view channel

Purchase of Biopharmaceutical Company Will Boost Development of Nitroxyl-Based Cardiovascular Disease Drugs

A major international biopharmaceutical company has announced the acquisition of a private biotech company that specializes in the development of drugs for treatment of cardiovascular disease. Bristol-Myers Squibb Co. (New York, NY, USA) has initiated the process to buy Cardioxyl Pharmaceuticals Inc. (Chapel Hill, NC, USA).... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.